We are live on ! Find out more
EI

Ethic Inc Portfolio holdings

AUM $8.02B
1-Year Est. Return 45.39%
This Fund
S&P 500
This Quarter Est. Return
+28.14%
1 Year Est. Return
+45.39%
3 Year Est. Return
+129.98%
5 Year Est. Return
+172.96%
10 Year Est. Return
AUM
$8.02B
AUM Growth
+$1.63B
Cap. Flow
+$552M
Cap. Flow %
6.89%
Top 10 Hldgs %
30.58%
Holding
1,454
New
219
Increased
729
Reduced
403
Closed
96

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$229M
2
NVDA icon
NVIDIA
NVDA
+$39.1M
3
AAPL icon
Apple
AAPL
+$35.4M
4
MSFT icon
Microsoft
MSFT
+$31.4M
5
AVGO icon
Broadcom
AVGO
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 37.77%
2 Financials 13.69%
3 Communication Services 9.75%
4 Industrials 9.38%
5 Healthcare 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYTX icon
1326
Kyverna Therapeutics
KYTX
$430M
$105K ﹤0.01%
11,823
-105
-0.9% -$932
LZ icon
1327
LegalZoom.com
LZ
$1.45B
$104K ﹤0.01%
+16,904
New +$104K
PLUG icon
1328
Plug Power
PLUG
$2.65B
$103K ﹤0.01%
37,949
-15,284
-29% -$48K
ORC
1329
Orchid Island Capital
ORC
$1.31B
$98.6K ﹤0.01%
14,145
-6,623
-32% -$45.6K
ACTG icon
1330
Acacia Research
ACTG
$437M
$91.7K ﹤0.01%
19,682
-348
-2% -$1.67K
LILAK icon
1331
Liberty Latin America Class C
LILAK
$1.69B
$87.4K ﹤0.01%
+11,218
New +$81.3K
DJT icon
1332
Trump Media & Technology Group
DJT
$2.73B
$87.4K ﹤0.01%
+11,286
New +$99.3K
RPD icon
1333
Rapid7
RPD
$628M
$87.2K ﹤0.01%
+10,763
New +$71.3K
TSHA icon
1334
Taysha Gene Therapies
TSHA
$1.61B
$85.2K ﹤0.01%
12,512
-474
-4% -$2.81K
PBYI icon
1335
Puma Biotechnology
PBYI
$398M
$83.3K ﹤0.01%
10,270
-260
-2% -$1.9K
PTON icon
1336
Peloton Interactive
PTON
$2.85B
$81.6K ﹤0.01%
+13,804
New +$74.5K
CIG icon
1337
CEMIG Preferred Shares
CIG
$6.06B
$77.6K ﹤0.01%
36,943
-29,551
-44% -$68.8K
RES icon
1338
RPC Inc
RES
$1.13B
$76.7K ﹤0.01%
13,160
-1,961
-13% -$13.7K
LCID icon
1339
Lucid Motors
LCID
$3.11B
$75.7K ﹤0.01%
+11,315
New +$73K
ABEO icon
1340
Abeona Therapeutics
ABEO
$355M
$70.1K ﹤0.01%
+11,344
New +$62.3K
VNDA icon
1341
Vanda Pharmaceuticals
VNDA
$304M
$69.7K ﹤0.01%
+11,386
New +$74.4K
NB
1342
NioCorp Developments
NB
$562M
$68.7K ﹤0.01%
+14,243
New +$78K
DCH
1343
Dauch Corp
DCH
$1.31B
$68.4K ﹤0.01%
12,616
-135
-1% -$820
MRVI icon
1344
Maravai LifeSciences
MRVI
$972M
$66.2K ﹤0.01%
10,604
-1,333
-11% -$5.75K
FNKO icon
1345
Funko
FNKO
$346M
$60.3K ﹤0.01%
10,258
-453
-4% -$2.18K
EPSN icon
1346
Epsilon Energy
EPSN
$168M
$59.9K ﹤0.01%
11,068
-8,697
-44% -$51.6K
HYLN icon
1347
Hyliion Holdings
HYLN
$578M
$58.9K ﹤0.01%
11,309
-1
-0% -$4
LRMR icon
1348
Larimar Therapeutics
LRMR
$377M
$54.5K ﹤0.01%
17,879
-17,572
-50% -$69.8K
TMCI icon
1349
Treace Medical Concepts
TMCI
$262M
$52.9K ﹤0.01%
+13,294
New +$36.5K
BDN
1350
Brandywine Realty Trust
BDN
$509M
$45.8K ﹤0.01%
14,451
-25,905
-64% -$77.9K

Similar funds

Ethic Inc's Q2 2026 Portfolio in Review

As of Q2 2026, Ethic Inc held 1,454 positions worth $8.02B, up 26% from $6.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ethic Inc deployed $552M of net new capital in Q2 2026, opening 219 new positions and adding to 729 existing holdings. Its largest new stake was Alphabet (Google) Class A: 636,505 shares worth $227M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $200M trimmed.

  • Ethic Inc's largest Q2 2026 buy was Alphabet (Google) Class A: 636,505 shares worth $227M.
  • Ethic Inc added most to NVIDIA in Q2 2026, an estimated $39.1M increase.
  • Ethic Inc's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $200M.
  • Ethic Inc fully exited Vanguard Emerging Markets Ex-China ETF in Q2 2026, selling an estimated $14.8M.
  • Ethic Inc's ten largest holdings make up 31% of its $8.02B portfolio in Q2 2026.
  • Ethic Inc opened 219 new positions and closed 96 in Q2 2026.
  • Ethic Inc's portfolio value rose 26% quarter-over-quarter to $8.02B.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.